- In January 2024, Eurofins Genomics inaugurated a certified sequencing lab in Bothell, Washington. This facility leverages the Oxford Nanopore platform to deliver rapid results within 12 hours. The lab has partnered with 30 Seattle-based labs to enhance its service reach and efficiency
- In February 2024, MGI Tech Co., Ltd. entered into a partnership with MetaGenoPolis, a unit within France's National Research Institute for Agriculture, Food and the Environment (INRAE). This collaboration followed MetaGenoPolis' selection as a core lab for the Million Microbiomes from Humans Project (MMHP). The partnership aims to advance metagenomics research by leveraging MGI's ultra-high throughput DNBSEQ-T7 sequencer to process samples from the project "Le French Gut" and other MMHP-related research
- In June 2023, Eurofins Genomics U.S. launched an express Oxford Nanopore sequencing service that offers same-day results2. This service leverages Gen3 NGS (next-generation sequencing) technology to provide a low-cost, whole plasmid sequencing solution with single-base accuracy of up to 99%2. The service aims to bridge the gap between Sanger and NGS by offering an affordable and fast solution for long-read sequencing
- In March 2023, Macrogen Inc. became the first company to introduce the NovaSeq X Plus system to Korea, marking its entry into the Asian market. This high-precision, whole-genome sequencing system, developed by Illumina, significantly boosts Macrogen's sequencing capacity and supports its genome foundry business. The installation of the NovaSeq X Plus at Macrogen's Genome Center in Korea was followed by plans to install additional units across its global affiliates, including in Japan and Europe
Frequently Asked Questions
The major factors driving the growth of the metagenomics market are rising awareness of the human microbiome and increased focus on precision medicine.
The primary challenges include high cost of sequencing and equipment and complexity of data analysis.
The sequencing technology segment dominates the metagenomics market. Advancements in next-generation sequencing (NGS) technologies have significantly reduced sequencing costs and improved data accuracy.
